Entera Bio (ENTX) Common Equity (2017 - 2026)
Entera Bio (ENTX) posted Common Equity of $7.27 million for Q2 2026, down 57.9% from $17.26 million a year earlier and down 32.0% from the prior quarter.
Powered by 
Analysis
Entera Bio (ENTX) Common Equity (2017 - 2026) Analysis & Trends
At the end of FY2025, Entera Bio's Common Equity came in at $13.1 million, up 62.1% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of 11.8% (FY2020 to FY2025).
- In prior years, Entera Bio's Common Equity was $8.08 million in FY2024 (-22.2%), $10.39 million in FY2023 (-11.6%), $11.75 million in FY2022 (-47.9%) and $22.57 million in FY2021 (+200.5%).
- The Q2 2026 figure stands as the lowest quarterly Common Equity since Q3 2024.
- On a year-over-year basis, Common Equity increased in five of the last eight quarters, with growth averaging 37.2%.
- The strongest year-over-year quarter for Common Equity in the past five years was Q4 2021, with growth of 200.5%; the weakest was Q2 2026, with a decline of 57.9%.
- According to Business Quant data, Common Equity for the three prior quarters was $10.69 million (Q1 2026), $13.1 million (Q4 2025) and $15.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Entera Bio | 132.59 Mn | 101.46 Mn | - | 7.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.27 Mn |
| Mar 31, 2026 | 10.69 Mn |
| Dec 31, 2025 | 13.10 Mn |
| Sep 30, 2025 | 15.23 Mn |
| Jun 30, 2025 | 17.26 Mn |
| Mar 31, 2025 | 19.38 Mn |
| Dec 31, 2024 | 8.08 Mn |
| Sep 30, 2024 | 6.45 Mn |
| Jun 30, 2024 | 8.53 Mn |
| Mar 31, 2024 | 8.86 Mn |
| Dec 31, 2023 | 10.39 Mn |
| Sep 30, 2023 | 6.24 Mn |
| Jun 30, 2023 | 8.23 Mn |
| Mar 31, 2023 | 10.08 Mn |
| Dec 31, 2022 | 11.75 Mn |
| Sep 30, 2022 | 14.31 Mn |
| Jun 30, 2022 | 17.27 Mn |
| Mar 31, 2022 | 19.75 Mn |
| Dec 31, 2021 | 22.57 Mn |
| Sep 30, 2021 | 26.28 Mn |
API Access
Entera Bio Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ENTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ENTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ENTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();